Sign in

IMRS on NASDAQ

IMRIS

IMRIS, founded in 2005, is a global provider of intraoperative imaging solutions. The company's flagship product is the IMRIS Surgical Theatre. A hybrid operating theatre with intraoperative imaging capabilities, The IMRIS Surgical Theatre incorporates design and technology provided by IMRIS, including the moveable intraoperative MRI, as well as technology from 3rd-party medical device companies.3 It is headquartered in Minnetonka.1 Its shares trade on NASDAQ under the symbol IMRS.1 Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

2005Founded1

Compare with another stock.

  • TickerIMRS on NASDAQ1
  • Industrymedical equipment1
  • HeadquartersMinnetonka1
  • Websitewww.imris.com
  • Listed onNasdaq (IMRS), Toronto Stock Exchange1

See how the biggest companies compare on our leaderboards

IMRIS, founded in 2005, is a global provider of intraoperative imaging solutions.3

What it owns

What IMRIS reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$26.1M5 Dec 31, 2014$26.4M5 Dec 31, 2013−1.2%
Accumulated depreciation$11.8M5 Dec 31, 2014$12.4M5 Dec 31, 2013−4.7%
Property and equipment, net$14.3M5 Dec 31, 2014$14.0M5 Dec 31, 2013+1.9%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$5.0M5 Dec 31, 2014$6.4M5 Dec 31, 2013−21.6%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$6.5M5 Dec 31, 2014$6.5M5 Dec 31, 20130%
Intangible assets, net (excluding goodwill)$7.9M5 Dec 31, 2014$9.0M5 Dec 31, 2013−12.2%
Finite-lived intangibles, gross$13.5M5 Dec 31, 2014$13.7M5 Dec 31, 2013−1.4%
Accumulated amortization$5.6M5 Dec 31, 2014$4.7M5 Dec 31, 2013+19.3%
Finite-lived intangibles, net$4.7M6 Dec 31, 2013$4.7M7 Dec 31, 2012+1.4%

Inventory

ItemLatestA year beforeChange
Inventory, total$9.1M5 Dec 31, 2014$10.0M5 Dec 31, 2013−8.7%
Raw materials$7.5M5 Dec 31, 2014$8.7M5 Dec 31, 2013−12.8%
Work in process$997.0K5 Dec 31, 2014$608.0K5 Dec 31, 2013+64.0%

The story

In 2005, IMRIS evolved from research related to intraoperative imaging conducted through Canada's National Research Council.

In 2011, the company announced it was developing an MRI-compatible image-guided surgical robot specifically designed for minimally invasive neurosurgery. In November 2012, the company announced that it was moving its headquarters to the Minneapolis area. They completed their move in July 2013.

In late May 2015, news broke that IMRIS had "filed for chapter 11 bankruptcy protection with a buyout offer of $9.5 million from secured lender Deerfield Management Co. LP." due to problems competing with larger health care businesses. Chapter 11 proceedings were finalized on August 19, 2015, with Deerfield Imaging agreeing to acquire most of IMRIS' assets.

In 2017, the company marked its second anniversary under new ownership, reporting strong financial growth and strategic investments. With the support of parent company Deerfield Management in August 2015, IMRIS emerged under a new LLC, brand, leadership and focus. Since then, IMRIS achieved record earnings and growth.

In 2021, Marc Buntaine, a seasoned medical device executive, was appointed CEO of IMRIS, Deerfield Imaging.

From Wikipedia’s article on IMRIS, shared under CC BY-SA 4.0.4

Products and brands

  • medical device

Listed on Wikidata.1

Timeline

  1. 2005Founded Founded1

SEC filer profile

How IMRIS is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARIMRIS Inc.2
  • CIK0001489161
  • Filer statusNon-accelerated filer2
  • Incorporated inCanada (Federal Level)2
  • Fiscal year endsDecember 312
  • Industry code (SIC)3845 Electromedical & Electrotherapeutic Apparatus2
  • Business address100-1370 Sony Place, Winnipeg, A2 R3T 1N52
  • Phone(204) 480-70902
  • Shares outstanding62,594,346 as of Dec 31, 20145
  • On EDGAR sinceNov 8, 20102
  • Filings185 in all: 6-K (123), SC 13G/A (19), SC 13G (10), 40-F (4), SUPPL (4), F-X (3), CORRESP (2), EFFECT (2)2
    All 23 form types

    F-10 (2), F-10/A (2), UPLOAD (2), 20-F (1), 25-NSE (1), 40-F/A (1), 424B3 (1), 8-A12B (1), 8-A12B/A (1), CERTNAS (1), D (1), F-10POS (1), F-3 (1), FWP (1), SD (1)

  • Latest filingsAnnual report (20-F) Apr 1, 2015

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7